SISTEMA DE EMBOLIZACIÓN DEANEURISMA WEB
ELSISTEMADEEMBOLIZACIÓNDEANEURISMAWEB ESTÁ DESTINADO A LA EMBOLIZACIÓNENDOVASCULAR DE ANEURISMASINTRACRANEALESROTOSYNOROTOSYOTRASANORMALIDADES NEUROVASCULARES COMOFÍSTULAS ARTERIOVENOSAS (FAV). TAMBIÉNESTÁDESTINADOALAOCLUSIÓNVASCULARDELOSVASOSSANGUÍNEOSDENTRODELSISTEMANEUROVASCULAR PARA OBSTRUIRPERMANENTEMENTE EL FLUJO SANGUÍNEO AUN ANEURISMA U OTRA MALFORMACIÓNVASCULAR.
THE WEBANEURYSM EMBOLIZATION SYSTEM IS INTENDED FOR ENDOVASCULAR EMBOLIZATION OF ROTOSYNOROTOS INTRACRANIAL ANEURYSMS AND OTHER NEUROVASCULAR ABNORMALITIES SUCH AS ARTERIOVENOUS FISTULAS (AVF). IT IS ALSO INTENDED FOR VASCULAR OCCLUSION OF BLOOD VESSELS WITHIN THE NEUROVASCULAR SYSTEM TO PERMANENTLY OBSTRUCT BLOOD FLOW EVEN ANEURYSM OR OTHER VASCULAR MALFORMATION.
- Risk Class / Clase de Riesgo
- Clase III
- Product Type (Spanish)
- II. PROTESIS, ÓRTESIS Y AYUDAS FUNCIONALES
- Product Type (English)
- II. PROSTHETICS, ORTHOSES AND FUNCTIONAL AIDS
- Trade Name (Spanish)
- DISPOSITIVO DE EMBOLIZACIÓNVASCULAR
- Trade Name (English)
- VASCULAR EMBOLIZATION DEVICE
- Analysis ID
- 686C2020 SSA
- Registration Date
- June 12, 2020
- Name (Spanish)
- LEVBETH MEDICAL, S.A. DE C.V.
- Name (English)
- LEVBETH MEDICAL, S.A. DE C.V.
Access comprehensive regulatory information for SISTEMA DE EMBOLIZACIÓN DEANEURISMA WEB (ANEURYSM EMBOLIZATION SYSTEM WEB) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 686C2020 SSA and manufactured by LEVBETH MEDICAL, S.A. DE C.V.. The device was registered on June 12, 2020.
This page provides complete registration details including product type (II. PROSTHETICS, ORTHOSES AND FUNCTIONAL AIDS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.